| Year |
Title |
Altmetric |
| 2019
|
PspA facilitates evasion of pneumococci from bactericidal activity of neutrophil extracellular traps (NETs).
Microbial Pathogenesis.
136.
2019
|
|
| 2019
|
Allergic airway sensitization impairs antibacterial IgG antibody responses during bacterial respiratory tract infections.
Journal of Allergy and Clinical Immunology.
143:1183-1197.e7.
2019
|
|
| 2019
|
The modified surface killing assay distinguishes between protective and nonprotective antibodies to PspA.
mSphere.
4.
2019
|
|
| 2018
|
Macrophage Rac2 is required to reduce the severity of cigarette smoke-induced pneumonia.
American Journal of Respiratory and Critical Care Medicine.
198:1288-1301.
2018
|
|
| 2018
|
The diversity of the proline-rich domain of pneumococcal surface protein A (PspA): Potential relevance to a broad-spectrum vaccine.
Vaccine.
36:6834-6843.
2018
|
|
| 2018
|
Novel immunoprotective proteins of Streptococcus pneumoniae identified by opsonophagocytosis killing screen.
Infection and Immunity.
86.
2018
|
|
| 2018
|
Transcutaneous immunization with pneumococcal surface protein A in mice.
Laryngoscope.
128:E91-E96.
2018
|
|
| 2018
|
Hyperencapsulated mucoid pneumococcal isolates from patients with cystic fibrosis have increased biofilm density and persistence in vivo.
Pathogens and Disease.
76.
2018
|
|
| 2017
|
Neutrophil extracellular traps and fibrin in otitis media: Analysis of human and chinchilla temporal bones.
JAMA Otolaryngology-Head and Neck Surgery.
143:990-995.
2017
|
|
| 2017
|
Dendritic cell-targeting DNA-based nasal adjuvants for protective mucosal immunity to Streptococcus pneumoniae.
Microbiology and Immunology.
61:195-205.
2017
|
|
| 2017
|
Inhibition of autolysis by lipase LipA in streptococcus pneumoniae sepsis.
Molecules and Cells.
40:935-944.
2017
|
|
| 2016
|
Pneumococcal pep27 mutant immunization stimulates cytokine secretion and confers long-term immunity with a wide range of protection, including against non-typeable strains.
Vaccine.
34:6481-6492.
2016
|
|
| 2016
|
The effects of differences in pspA alleles and capsular types on the resistance of Streptococcus pneumoniae to killing by apolactoferrin.
Microbial Pathogenesis.
99:209-219.
2016
|
|
| 2016
|
Pneumolysin plays a key role at the initial step of establishing pneumococcal nasal colonization.
Folia Microbiologica.
61:375-383.
2016
|
|
| 2016
|
PcpA promotes higher levels of infection and modulates recruitment of myeloid-derived suppressor cells during pneumococcal pneumonia.
Journal of Immunology.
196:2239-2248.
2016
|
|
| 2016
|
Free sialic acid acts as a signal that promotes streptococcus pneumoniae invasion of nasal tissue and nonhematogenous invasion of the central nervous system.
Infection and Immunity.
84:2607-2615.
2016
|
|
| 2015
|
The effects of CFTR and mucoid phenotype on susceptibility and innate immune responses in a mouse model of pneumococcal lung disease.
PLoS ONE.
10.
2015
|
|
| 2015
|
Multivalent pneumococcal protein vaccines comprising pneumolysoid with epitopes/fragments of CbpA and/or PspA elicit strong and broad protection.
Clinical and Diagnostic Laboratory Immunology.
22:1079-1089.
2015
|
|
| 2015
|
ClpL is a chaperone without auxiliary factors.
European Journal of Biochemistry.
282:1352-1367.
2015
|
|
| 2015
|
A molecular mucosal adjuvant to enhance immunity against pneumococcal infection in the elderly..
Immune Network.
15:9-15.
2015
|
|
| 2015
|
Evaluation of a vaccine formulation against Streptococcus pneumoniae based on choline-binding proteins..
Clinical and Diagnostic Laboratory Immunology.
22:213-220.
2015
|
|
| 2015
|
A bivalent conjugate vaccine containing PspA families 1 and 2 has the potential to protect against a wide range of Streptococcus pneumoniae strains and Salmonella Typhi.
Vaccine.
33:783-788.
2015
|
|
| 2015
|
Current status and perspectives on protein-based pneumococcal vaccines.
CRC critical reviews in microbiology.
41:190-200.
2015
|
|
| 2015
|
Ethanol-induced alcohol dehydrogenase E (AdhE) potentiates pneumolysin in Streptococcus pneumoniae.
Infection and Immunity.
83:108-119.
2015
|
|
| 2015
|
Nanogel-based pneumococcal surface protein A nasal vaccine induces microRNA-associated Th17 cell responses with neutralizing antibodies against Streptococcus pneumoniae in macaques.
Mucosal Immunology.
8:1144-1153.
2015
|
|
| 2015
|
Streptococcus pneumoniae induces pyroptosis through the regulation of autophagy in murine microglia.
Oncotarget.
6:44161-44178.
2015
|
|
| 2014
|
Basophil expansion protects against invasive pneumococcal disease in mice.
Journal of Infectious Diseases.
210:14-24.
2014
|
|
| 2014
|
Mapping of epitopes recognized by antibodies induced by immunization of mice with PspA and PspC.
Clinical and Diagnostic Laboratory Immunology.
21:940-948.
2014
|
|
| 2014
|
Mouse, but Not Human, ApoB-100 Lipoprotein Cholesterol Is a Potent Innate Inhibitor of Streptococcus pneumoniae Pneumolysin.
PLoS Pathogens.
10.
2014
|
|
| 2014
|
Pneumococcal PspA and PspC proteins: Potential vaccine candidates for experimental otitis media.
International Journal of Pediatric Otorhinolaryngology.
78:1517-1521.
2014
|
|
| 2014
|
Protective properties of a fusion pneumococcal surface protein A (PspA) vaccine against pneumococcal challenge by five different PspA clades in mice.
Vaccine.
32:5607-5613.
2014
|
|
| 2013
|
A modified surface killing assay (MSKA) as a functional in vitro assay for identifying protective antibodies against pneumococcal surface protein A (PspA).
Vaccine.
32:39-47.
2013
|
|
| 2013
|
Invasive and Noninvasive Streptococcus pneumoniae Capsule and Surface Protein Diversity following the Use of a Conjugate Vaccine.
Clinical and Diagnostic Laboratory Immunology.
20:1711-1718.
2013
|
|
| 2013
|
Asthma and antibodies to pneumococcal virulence proteins.
Infection.
41:927-934.
2013
|
|
| 2013
|
Modified opsonization, phagocytosis, and killing assays to measure potentially protective antibodies against pneumococcal surface protein A.
Clinical and Diagnostic Laboratory Immunology.
20:1549-1558.
2013
|
|
| 2013
|
Retention of structure, antigenicity, and biological function of pneumococcal surface protein A (PspA) released from polyanhydride nanoparticles.
Acta Biomaterialia.
9:8262-8271.
2013
|
|
| 2013
|
Viability and virulence of pneumolysin, pneumococcal surface protein a, and pneumolysin/pneumococcal surface protein a mutants in the ear.
JAMA Otolaryngology-Head and Neck Surgery.
139:937-943.
2013
|
|
| 2013
|
Nanogel-based pspa intranasal vaccine prevents invasive disease and nasal colonization by streptococcus pneumoniae.
Infection and Immunity.
81:1625-1634.
2013
|
|
| 2013
|
The link between antibodies to oxldl and natural protection against pneumococci depends on dh gene conservation.
Journal of Experimental Medicine.
210:875-890.
2013
|
|
| 2013
|
PspA Family Distribution, Antimicrobial Resistance and Serotype of Streptococcus pneumoniae Isolated from Upper Respiratory Tract Infections in Japan.
PLoS ONE.
8.
2013
|
|
| 2013
|
Inactivated pep27 mutant as an effective mucosal vaccine against a secondary lethal pneumococcal challenge in mice..
Clinical and Experimental Vaccine Research.
2:58-65.
2013
|
|
| 2012
|
Pneumococcal surface protein A inhibits complement deposition on the pneumococcal surface by competing with the binding of C-reactive protein to cell-surface phosphocholine.
Journal of Immunology.
189:5327-5335.
2012
|
|
| 2012
|
The absence of PspA or presence of antibody to PspA facilitates the complement-dependent phagocytosis of pneumococci In Vitro.
Clinical and Diagnostic Laboratory Immunology.
19:1574-1582.
2012
|
|
| 2012
|
Specific immunization strategies against oxidized low-density lipoprotein: A novel way to reduce nonalcoholic steatohepatitis in mice.
Hepatology.
56:894-903.
2012
|
|
| 2012
|
Hepatic induction of cholesterol biosynthesis reflects a remote adaptive response to pneumococcal pneumonia.
Federation proceedings.
26:2424-2436.
2012
|
|
| 2012
|
PspA family distribution, unlike capsular serotype, remains unaltered following introduction of the heptavalent pneumococcal conjugate vaccine.
Clinical and Diagnostic Laboratory Immunology.
19:891-896.
2012
|
|
| 2012
|
Nontypeable pneumococci can be divided into multiple cps types, including one type expressing the novel gene pspK.
mBio.
3.
2012
|
|
| 2012
|
Streptococcus pneumoniae pep27 mutant as a live vaccine for serotype-independent protection in mice.
Vaccine.
30:2008-2019.
2012
|
|
| 2012
|
CCL5-independent helper T lymphocyte responses to immuno-dominant pneumococcal surface protein A epitopes.
Vaccine.
30:1181-1190.
2012
|
|
| 2011
|
Maternal immunization with pneumococcal surface protein A protects against pneumococcal infections among derived offspring.
PLoS ONE.
6.
2011
|
|
| 2011
|
Elicitation of mucosal immunity by proteins of streptococcus pneumoniae.
Advances in Otorhinolaryngology.
72:25-27.
2011
|
|
| 2011
|
Heat-shock protein ClpL/HSP100 increases penicillin tolerance in streptococcus pneumoniae.
Advances in Otorhinolaryngology.
72:126-128.
2011
|
|
| 2011
|
Protection of pneumococcal infection by maternal intranasal immunization with pneumococcal surface protein A.
Advances in Otorhinolaryngology.
72:121-125.
2011
|
|
| 2011
|
The nasal dendritic cell-targeting Flt3 ligand as a safe adjuvant elicits effective protection against fatal pneumococcal pneumonia.
Infection and Immunity.
79:2819-2828.
2011
|
|
| 2011
|
Decrease in penicillin susceptibility due to heat shock protein ClpL in Streptococcus pneumoniae.
Antimicrobial Agents and Chemotherapy.
55:2714-2728.
2011
|
|
| 2011
|
Exposure of Thomsen-Friedenreich antigen in Streptococcus pneumoniae infection is dependent on pneumococcal neuraminidase A.
Microbial Pathogenesis.
50:343-349.
2011
|
|
| 2011
|
Serine protease PrtA from Streptococcus pneumoniae plays a role in the killing of S. pneumoniae by apolactoferrin.
Infection and Immunity.
79:2440-2450.
2011
|
|
| 2011
|
Streptococcus pneumoniae isolates from middle ear fluid and nasopharynx of children with acute otitis media exhibit phase variation.
Journal of Clinical Microbiology.
49:1646-1649.
2011
|
|
| 2011
|
Erratum to " Effective induction of protective systemic immunity with nasally administered vaccines adjuvanted with IL-1" [Vaccine 28 (42) (2010) 6901-6914].
Vaccine.
29:2821.
2011
|
|
| 2011
|
A combination of Flt3 ligand cDNA and CpG oligodeoxynucleotide as nasal adjuvant elicits protective secretory-IgA immunity to Streptococcus pneumoniae in aged mice.
Journal of Immunology.
186:2454-2461.
2011
|
|
| 2010
|
Effect of apolactoferrin on experimental pneumococcal otitis media.
Archives of Otolaryngology Head and Neck Surgery.
136:1127-1131.
2010
|
|
| 2010
|
Effective induction of protective systemic immunity with nasally administered vaccines adjuvanted with IL-1.
Vaccine.
28:6901-6914.
2010
|
|
| 2010
|
Secretory-IgA antibodies play an important role in the immunity to Streptococcus pneumoniae.
Journal of Immunology.
185:1755-1762.
2010
|
|
| 2010
|
Complement receptor 1 expression on mouse erythrocytes mediates clearance of Streptococcus pneumoniae by immune adherence.
Infection and Immunity.
78:3129-3135.
2010
|
|
| 2010
|
Importance of CXC chemokine receptor 2 in alveolar neutrophil and exudate macrophage recruitment in response to pneumococcal lung infection.
Infection and Immunity.
78:2620-2630.
2010
|
|
| 2010
|
Influenza A virus facilitates Streptococcus pneumoniae transmission and disease.
Federation proceedings.
24:1789-1798.
2010
|
|
| 2010
|
Protection against nasal colonization with Streptococcus pneumoniae by parenteral immunization with a DNA vaccine encoding PspA (Pneumococcal surface protein A).
Microbial Pathogenesis.
48:205-213.
2010
|
|
| 2010
|
The proline-rich region of pneumococcal surface proteins A and C contains surface-accessible epitopes common to all pneumococci and elicits antibody-mediated protection against sepsis.
Infection and Immunity.
78:2163-2172.
2010
|
|
| 2010
|
Helper T cell epitope-mapping reveals MHC-peptide binding affinities that correlate with T helper cell responses to pneumococcal surface protein A.
PLoS ONE.
5.
2010
|
|
| 2010
|
Efficacy profiles of daptomycin for treatment of invasive and noninvasive pulmonary infections with Streptococcus pneumoniae.
Antimicrobial Agents and Chemotherapy.
54:707-717.
2010
|
|
| 2009
|
Virulence of pneumococcal proteins on the inner ear.
Archives of Otolaryngology Head and Neck Surgery.
135:657-661.
2009
|
|
| 2009
|
Important role for CC chemokine ligand 2-dependent lung mononuclear phagocyte recruitment to inhibit sepsis in mice infected with Streptococcus pneumoniae.
Journal of Immunology.
182:4931-4937.
2009
|
|
| 2009
|
Mucosal immunization with polyamine transport protein D (PotD) protects mice against nasopharyngeal colonization with Streptococcus pneumoniae.
Proceedings of the Society for Experimental Biology and Medicine.
234:403-409.
2009
|
|
| 2009
|
Mucosal vaccination with a multicomponent adenovirus-vectored vaccine protects against Streptococcus pneumoniae infection in the lung.
FEMS Immunology and Medical Microbiology.
55:346-351.
2009
|
|
| 2009
|
Antibody to the type 3 capsule facilitates immune adherence of pneumococci to erythrocytes and augments their transfer to macrophages.
Infection and Immunity.
77:464-471.
2009
|
|
| 2008
|
Role of pneumococcal proteins in sensorineural hearing loss due to otitis media.
American Journal of Otology -New York-.
29:1056-1060.
2008
|
|
| 2008
|
Development of antibodies to PspA families 1 and 2 in children after exposure to Streptococcus pneumoniae.
Clinical and Diagnostic Laboratory Immunology.
15:1529-1535.
2008
|
|
| 2008
|
Distribution of pneumococcal surface protein A families 1 and 2 among Streptococcus pneumoniae isolates from children in Finland who had acute otitis media or were nasopharyngeal carriers.
Clinical and Diagnostic Laboratory Immunology.
15:1555-1563.
2008
|
|
| 2008
|
PIR-B-deficient mice are susceptible to Salmonella infection.
Journal of Immunology.
181:4229-4239.
2008
|
|
| 2008
|
Prospects for use of interleukin-12 as a mucosal adjuvant for vaccination of humans to protect against respiratory pneumococcal infection.
Vaccine.
26:4893-4903.
2008
|
|
| 2008
|
Basophils enhance immunological memory responses.
Nature Immunology.
9:733-742.
2008
|
|
| 2008
|
Streptococcus pneumoniae surface protein PcpA elicits protection against lung infection and fatal sepsis.
Infection and Immunity.
76:2767-2776.
2008
|
|
| 2008
|
The round window membrane in otitis media: Effect of pneumococcal proteins.
Archives of Otolaryngology Head and Neck Surgery.
134:658-662.
2008
|
|
| 2008
|
Effect of high dose oral zinc in mice with severe infection with Streptococcus pneumoniae.
Scandinavian Journal of Infectious Diseases.
40:363-367.
2008
|
|
| 2008
|
Vaccine-induced human antibodies to PspA augment complement C3 deposition on Streptococcus pneumoniae.
Microbial Pathogenesis.
44:204-214.
2008
|
|
| 2008
|
Macrophage turnover kinetics in the lungs of mice infected with Streptococcus pneumoniae.
American Journal of Respiratory Cell and Molecular Biology.
38:105-113.
2008
|
|
| 2007
|
Fusion proteins containing family 1 and family 2 PspA fragments elicit protection against Streptococcus pneumoniae that correlates with antibody-mediated enhancement of complement deposition.
Infection and Immunity.
75:5930-5938.
2007
|
|
| 2007
|
PspA and PspC minimize immune adherence and transfer of pneumococci from erythrocytes to macrophages through their effects on complement activation.
Infection and Immunity.
75:5877-5885.
2007
|
|
| 2007
|
Antibodies to pneumococcal surface protein A families 1 and 2 in serum and saliva of children and the risk of pneumococcal acute otitis media.
Journal of Infectious Diseases.
196:1528-1536.
2007
|
|
| 2007
|
Antibody-independent, CD4+ T-cell-dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins.
Infection and Immunity.
75:5460-5464.
2007
|
|
| 2007
|
FMS-like tyrosine kinase 3 ligand aggravates the lung inflammatory response to Streptococcus pneumoniae infection in mice: Role of dendritic cells.
Journal of Immunology.
179:3099-3108.
2007
|
|
| 2007
|
Tumor Suppressor CYLD Regulates Acute Lung Injury in Lethal Streptococcus pneumoniae Infections.
Immunity.
27:349-360.
2007
|
|
| 2007
|
Structure of a Complex of Human Lactoferrin N-lobe with Pneumococcal Surface Protein A Provides Insight into Microbial Defense Mechanism.
Journal of Molecular Biology.
370:701-713.
2007
|
|
| 2007
|
Effects of chronic stress and interleukin-10 gene polymorphisms on antibody response to tetanus vaccine in family caregivers of patients with Alzheimer's disease.
Psychosomatic Medicine.
69:551-559.
2007
|
|
| 2007
|
Importance of phosphoinositide 3-kinase γ in the host defense against pneumococcal infection.
American Journal of Respiratory and Critical Care Medicine.
175:958-966.
2007
|
|
| 2007
|
Lung-specific overexpression of CC chemokine ligand (CCL) 2 enhances the host defense to Streptococcus pneumoniae infection in mice: Mole of the CCL2-CCR2 axis.
Journal of Immunology.
178:5828-5838.
2007
|
|
| 2007
|
Contributions of pneumolysin, pneumococcal surface protein A (PspA), and PspC to pathogenicity of Streptococcus pneumoniae D39 in a mouse model.
Infection and Immunity.
75:1843-1851.
2007
|
|
| 2007
|
Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae.
Infection and Immunity.
75:350-357.
2007
|
|
| 2006
|
Serum antibodies to pneumococcal neuraminidase NanA in relation to pneumococcal carriage and acute otitis media.
Clinical and Diagnostic Laboratory Immunology.
13:1177-1179.
2006
|
|
| 2006
|
Pneumococcal surface protein A (PspA) is effective at eliciting T cell-mediated responses during invasive pneumococcal disease in adults.
Clinical and Experimental Immunology.
145:277-286.
2006
|
|
| 2006
|
Capsule does not block antibody binding to PspA, a surface virulence protein of Streptococcus pneumoniae.
Microbial Pathogenesis.
40:228-233.
2006
|
|
| 2006
|
CCL5 modulates pneumococcal immunity and carriage.
Journal of Immunology.
176:2346-2356.
2006
|
|
| 2006
|
Mn2+-dependent regulation of multiple genes in Streptococcus pneumoniae through PsaR and the resultant impact on virulence.
Infection and Immunity.
74:1171-1180.
2006
|
|
| 2006
|
Pneumococcal surface protein A (PspA) family distribution among clinical isolates from adults over 50 years of age collected in seven countries.
Journal of Medical Microbiology.
55:215-221.
2006
|
|
| 2006
|
Bacterial interference of penicillin-sensitive and -resistant Streptococcus pneumoniae by Streptococcus oralis in an adenoid organ culture: Implications for the treatment of recurrent upper respiratory tract infections in children and adults.
Annals of Otology Rhinology and Laryngology.
115:350-356.
2006
|
|
| 2005
|
Nasal colonization with Streptococcus pneumoniae includes subpopulations of surface and invasive pneumococci.
Infection and Immunity.
73:6945-6951.
2005
|
|
| 2005
|
Antibodies to the pneumococcal surface protein A, PspA, can be produced in splenectomized mice and can protect splenectomized mice from infection with Streptococcus pneumoniae.
Vaccine.
23:4257-4262.
2005
|
|
| 2005
|
Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae.
Infection and Immunity.
73:1304-1312.
2005
|
|
| 2005
|
Differential PsaA-, PspA-, PspC-, and PdB-specific immune responses in a mouse model of pneumococcal carriage.
Infection and Immunity.
73:1006-1013.
2005
|
|
| 2005
|
PspA family typing and PCR-based DNA fingerprinting with BOX A1R primer of pneumococci from the blood of patients in the USA with and without sickle cell disease.
Epidemiology and Infection.
133:173-178.
2005
|
|
| 2005
|
Relative fitness of fluoroquinolone-resistant Streptococcus pneumoniae.
Emerging Infectious Diseases.
11:814-820.
2005
|
|
| 2004
|
Characterization of antibodies to PspA and PsaA in adults over 50 years of age with invasive pneumococcal disease.
Vaccine.
23:789-793.
2004
|
|
| 2004
|
The virulence function of Streptococcus pneumoniae surface protein A involves inhibition of complement activation and impairment of complement receptor-mediated protection.
Journal of Immunology.
173:7506-7512.
2004
|
|
| 2004
|
Erratum: PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin (Infection and Immunity (2004) 72, 9 (5031-5040)).
Infection and Immunity.
72:7379.
2004
|
|
| 2004
|
Lipoprotein PsaA in virulence of Streptococcus pneumoniae: Surface accessibility and role in protection from superoxide.
Infection and Immunity.
72:5858-5867.
2004
|
|
| 2004
|
PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin.
Infection and Immunity.
72:5031-5040.
2004
|
|
| 2004
|
Erratum: Pneumococcal carriage results in ganglioside-mediated olfactory tissue infection (Proceeding of the National Academy of Sciences of the United States of America (November 25, 2003) 100, 24 (14363-14367)).
Proceedings of the National Academy of Sciences.
101:6834.
2004
|
|
| 2004
|
Invasive Streptococcus pneumoniae isolates from Argentinian children: Serotypes, families of pneumococcal surface protein A (PspA) and genetic diversity.
Epidemiology and Infection.
132:177-184.
2004
|
|
| 2004
|
Natural materno-fetal transfer of antibodies to PspA and to PsaA.
Clinical and Experimental Immunology.
135:474-477.
2004
|
|
| 2004
|
Effects of PspA and Antibodies to PspA on Activation and Deposition of Complement on the Pneumococcal Surface.
Infection and Immunity.
72:114-122.
2004
|
|
| 2004
|
Protection of the elderly from pneumococcal pneumonia with a protein-based vaccine?.
Mechanisms of Ageing and Development.
125:129-131.
2004
|
|
| 2003
|
Pneumococcal Surface Protein A Is Expressed in Vivo, and Antibodies to PspA Are Effective for Therapy in a Murine Model of Pneumococcal Sepsis.
Infection and Immunity.
71:7149-7153.
2003
|
|
| 2003
|
Pneumococcal proteins that may constitute the next generation vaccine for pneumococcal disease.
International Congress Series.
1257:27-31.
2003
|
|
| 2003
|
Pneumococcal carriage results in ganglioside-mediated olfactory tissue infection.
Proceedings of the National Academy of Sciences.
100:14363-14367.
2003
|
|
| 2003
|
Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae.
Journal of Infectious Diseases.
188:339-348.
2003
|
|
| 2003
|
Increased protection against pneumococcal disease by mucosal administration of conjugate vaccine plus interleukin-12.
Infection and Immunity.
71:4780-4788.
2003
|
|
| 2003
|
Relative roles of genetic background and variation in PspA in the ability of antibodies to PspA to protect against capsular type 3 and 4 strains of Streptococcus pneumoniae.
Infection and Immunity.
71:4498-4505.
2003
|
|
| 2003
|
Effects of zinc deficiency and pneumococcal surface protein A immunization on zinc status and the risk of severe infection in mice.
Infection and Immunity.
71:2009-2013.
2003
|
|
| 2003
|
Immunogenic protein contaminants in pneumococcal vaccines.
Journal of Infectious Diseases.
187:1019-1023.
2003
|
|
| 2003
|
Regions of PspA/EF3296 best able to elicit protection against Streptococcus pneumoniae in a murine infection model.
Infection and Immunity.
71:1033-1041.
2003
|
|
| 2003
|
Both family 1 and family 2 PspA proteins can inhibit complement deposition and confer virulence to a capsular serotype 3 strain of Streptococcus pneumoniae.
Infection and Immunity.
71:75-85.
2003
|
|
| 2002
|
Complement receptors CD21/35 link innate and protective immunity during Streptococcus pneumoniae infection by regulating IgG3 antibody responses.
Immunity.
17:713-723.
2002
|
|
| 2002
|
Evolution and virulence of serogroup 6 pneumococci on a global scale.
Journal of Bacteriology.
184:6367-6375.
2002
|
|
| 2002
|
Characterization of the dihydrolipoamide dehydrogenase from Streptococcus pneumoniae and its role in pneumococcal infection.
Microbiological sciences.
44:431-448.
2002
|
|
| 2002
|
Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae.
Infection and Immunity.
70:2526-2534.
2002
|
|
| 2001
|
Pneumococcal surface protein A of invasive Streptococcus pneumoniae isolates from Colombian children.
Emerging Infectious Diseases.
7:832-836.
2001
|
|
| 2001
|
Intranasal vaccination with pneumococcal surface protein A and Interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection.
Infection and Immunity.
69:6718-6724.
2001
|
|
| 2001
|
Pneumococcal pulmonary infection, septicaemia and survival in young zinc-depleted mice.
British Journal of Nutrition.
86:301-306.
2001
|
|
| 2001
|
Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci.
Infection and Immunity.
69:4870-4873.
2001
|
|
| 2001
|
Clones of Streptococcus pneumoniae isolated from nasopharyngeal carriage and invasive disease in young children in central Tennessee.
Journal of Infectious Diseases.
183:1501-1507.
2001
|
|
| 2001
|
Characterization of binding of human lactoferrin to pneumococcal surface protein A.
Infection and Immunity.
69:3372-3381.
2001
|
|
| 2001
|
The autolytic enzyme lytA of Streptococcus pneumoniae is not responsible for releasing pneumolysin.
Journal of Bacteriology.
183:3108-3116.
2001
|
|
| 2001
|
IL-12-mediated increases in protection elicited by pneumococcal and meningococcal conjugate vaccines.
Vaccine.
19:2020-2028.
2001
|
|
| 2001
|
Immunologic compensation in a patient with a large IgH constant region deletion.
Journal of Allergy and Clinical Immunology.
107:1051-1055.
2001
|
|
| 2001
|
Streptococcus pneumoniae: New tools for an old pathogen.
Current Opinion in Microbiology.
4:71-77.
2001
|
|
| 2000
|
The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae.
Vaccine.
19.
2000
|
|
| 2000
|
Erratum: Competition among Streptococcus pneumoniae for intranasal colonization in amouse model (Vaccine (2000) 18 (2895-2901) PII: S0264410X00000463).
Vaccine.
19:598.
2000
|
|
| 2000
|
Competition among Streptococcus pneumoniae for intranasal colonization in a mouse model.
Vaccine.
18:2895-2901.
2000
|
|
| 2000
|
Development of a multi-specificity opsonophagocytic killing assay.
Vaccine.
18:2768-2771.
2000
|
|
| 2000
|
A latex bead-based flow cytometric immunoassay capable of simultaneous typing of multiple pneumococcal serotypes (multibead assay).
Clinical and Diagnostic Laboratory Immunology.
7:486-489.
2000
|
|
| 2000
|
Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae.
Infection and Immunity.
68:3028-3033.
2000
|
|
| 2000
|
Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules.
Vaccine.
18:1743-1754.
2000
|
|
| 2000
|
Purification and characterization of Streptococcus pneumoniae palmitoylated pneumococcal surface adhesin A expressed in Escherichia coli.
Vaccine.
18:1811-1821.
2000
|
|
| 2000
|
The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection.
Vaccine.
18:1707-1711.
2000
|
|
| 2000
|
Acquired, but not innate, immune responses to Streptococcus pneumoniae are compromised by neutralization of CD40L.
Infection and Immunity.
68:511-517.
2000
|
|
| 2000
|
Human antibodies to pneumococcal surface protein A in health and disease.
Pediatric Infectious Disease Journal.
19:134-138.
2000
|
|
| 2000
|
Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae.
Infection and Immunity.
68:796-800.
2000
|
|
| 2000
|
Diversity of PspA: Mosaic genes and evidence for past recombination in Streptococcus pneumoniae.
Infection and Immunity.
68:5889-5900.
2000
|
|
| 2000
|
Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA.
Journal of Infectious Diseases.
182:1694-1701.
2000
|
|
| 2000
|
Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media.
Journal of Infectious Diseases.
182:1146-1152.
2000
|
|
| 2000
|
Pathway analysis in metabolic databases via differential metabolic display (DMD).
Computer applications in the biosciences : CABIOS.
16:825-836.
2000
|
|
| 2000
|
Production and characterization of the functional fragment of pneumococcal surface protein A.
Archives of Biochemistry and Biophysics.
373:116-125.
2000
|
|
| 1999
|
The pspC gene of Streptococcus pneumoniae encodes a polymorphic protein, PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremia.
Infection and Immunity.
67:6533-6542.
1999
|
|
| 1999
|
Pneumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae.
Infection and Immunity.
67:4720-4724.
1999
|
|
| 1999
|
In vivo polysaccharide-specific IgG isotype responses to intact Streptococcus pneumoniae are T cell dependent and require CD40- and B7- ligand interactions.
Journal of Immunology.
163:659-667.
1999
|
|
| 1999
|
Effects of active immunization with a pneumococcal surface protein (PspA) and of locally applied antibodies in experimental otitis media.
ORL.
61:206-211.
1999
|
|
| 1999
|
Molecular characterization of a globally distributed lineage of serotype 12F Streptococcus pneumoniae causing invasive disease.
Journal of Infectious Diseases.
179:414-422.
1999
|
|
| 1999
|
Immunization and protection in pneumococcal otitis media studied in a rat model.
Microbial Drug Resistance.
5:73-82.
1999
|
|
| 1999
|
Tumor necrosis factor alpha receptor I is important for survival from Streptococcus pneumoniae infections.
Infection and Immunity.
67:595-601.
1999
|
|
| 1998
|
A nontoxic adjuvant for mucosal immunity to pneumococcal surface protein A.
Journal of Immunology.
161:4115-4121.
1998
|
|
| 1998
|
Comparison of the PspA sequence from Streptococcus pneumoniae EF5668 to the previously identified PspA sequence from strain Rx1 and ability of PspA from EF5668 to elicit protection against pneumococci of different capsular types..
Infection and Immunity.
66:4748-4754.
1998
|
|
| 1998
|
Pneumococcal diversity: Considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA).
Clinical Microbiology Reviews.
11:645-657.
1998
|
|
| 1998
|
The IS1167 insertion sequence is a phylogenetically informative marker among isolates of serotype 6B Streptococcus pneumoniae.
Journal of Molecular Evolution.
47:222-229.
1998
|
|
| 1998
|
Enhanced Protective Antibody Responses to PspA after Intranasal or Subcutaneous Injections of PspA Genetically Fused to Granulocyte-Macrophage Colony-Stimulating Factor or Interleukin-2.
Infection and Immunity.
66:1513-1520.
1998
|
|
| 1998
|
Role of tumor necrosis factor alpha in the host response of mice to bacteremia caused by pneumolysin-deficient Streptococcus pneumoniae.
Infection and Immunity.
66:839-842.
1998
|
|
| 1998
|
A live recombinant avirulent oral Salmonella vaccine expressing pneumococcal surface protein a induces protective responses against Streptococcus pneumoniae.
Infection and Immunity.
66:3744-3751.
1998
|
|
| 1997
|
Development of a model of low-inoculum Streptococcus pneumoniae intrapulmonary infection in infant rats.
Infection and Immunity.
65:4701-4704.
1997
|
|
| 1997
|
Differences in virulence for mice among Streptococcus pneumoniae strains of capsular types 2, 3, 4, 5, and 6 are not attributable to differences in pneumolysin production.
Infection and Immunity.
65:1237-1244.
1997
|
|
| 1997
|
Oligonucleotides identify conserved and variable regions of pspA and pspA-like sequences of Streptococcus pneumoniae.
Gene.
188:279-284.
1997
|
|
| 1997
|
Oral immunization with PspA elicits protective humoral immunity against Streptococcus pneumoniae infection.
Infection and Immunity.
65:640-644.
1997
|
|
| 1997
|
Establishment of a Streptococcus pneumoniae nasopharyngeal colonization model in adult mice.
Microbial Pathogenesis.
23:127-137.
1997
|
|
| 1997
|
Immunization with a plasmid expressing pneumococcal surface protein A (PspA) can elicit protection against fatal infection with Streptococcus pneumoniae.
Gene Therapy.
4:375-377.
1997
|
|
| 1997
|
Intranasal immunization of mice with PspA (Pneumococcal surface protein A) can prevent lntranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae.
Journal of Infectious Diseases.
175:839-846.
1997
|
|
| 1997
|
PspA and PspC: Their potential for use as pneumococcal vaccines.
Microbial Drug Resistance.
3:401-408.
1997
|
|
| 1997
|
The hemolytic and complement-activating properties of pneumolysin do not contribute individually to virulence in a pneumococcal bacteremia model.
Microbial Pathogenesis.
23:201-209.
1997
|
|
| 1996
|
Resistance to mycoplasmal lung disease in mice is a complex genetic trait.
Infection and Immunity.
64:5326-5331.
1996
|
|
| 1996
|
Complement-dependence of c-reactive protein (crp)-mediated protection of mice from streptococcus pneumoniae.
Federation proceedings.
10.
1996
|
|
| 1996
|
Recombinant cholera toxin B subuntt (RCTB) as a mucosal adjuvant.
Federation proceedings.
10.
1996
|
|
| 1996
|
Role of complement in C-reactive-protein-mediated protection of mice from Streptococcus pneumoniae.
Infection and Immunity.
64:4850-4853.
1996
|
|
| 1996
|
DNA polymorphisms and variant penicillin-binding proteins as evidence that relatively penicillin-resistant pneumococci in Western Canada are clonally related.
Journal of Infectious Diseases.
174:884-888.
1996
|
|
| 1996
|
Pneumococcal vaccine response in human immunodeficiency virus-infected patients.
Journal of Infectious Diseases.
173:777-778.
1996
|
|
| 1996
|
Evidence for the simultaneous expression of two PspAs by a clone of capsular serotype 6B Streptococcus pneumoniae.
Microbial Pathogenesis.
21:265-275.
1996
|
|
| 1996
|
PspA, a protection-eliciting pneumococcal protein: Immunogenicity of isolated native PspA in mice.
Vaccine.
14:858-867.
1996
|
|
| 1996
|
Systemic and mucosal protective immunity to pneumococcal surface protein A.
Annals of the New York Academy of Sciences.
797:118-126.
1996
|
|
| 1996
|
Truncated Streptococcus pneumoniae PspA molecules elicit cross-protective immunity against pneumococcal challenge in mice.
Journal of Infectious Diseases.
173:380-386.
1996
|
|
| 1995
|
A pneumolysin-negative mutant of Streptococcus pneumoniae causes chronic bacteremia rather than acute sepsis in mice.
Infection and Immunity.
63:448-455.
1995
|
|
| 1995
|
Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice.
Journal of Immunology.
155:2557-2563.
1995
|
|
| 1994
|
Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille calmette-guárin vaccines expressing pneumococcal surface protein A.
Journal of Experimental Medicine.
180:2277-2286.
1994
|
|
| 1994
|
Cross‐Reactive Protection Eliciting Epitopes of Pneumococcal Surface Protein A.
Annals of the New York Academy of Sciences.
730:361-363.
1994
|
|
| 1994
|
Localization of protection-eliciting epitopes on pspa of streptococcus pneumoniae between amino acid residues 192 and 260.
Microbial Pathogenesis.
17:323-337.
1994
|
|
| 1994
|
The intracellular nature of Salmonella infection during the early stages of mouse typhoid..
Immunology series.
60:303-312.
1994
|
|
| 1993
|
Immunology of tuberculosis.
Medical Clinics of North America.
77:1235-1251.
1993
|
|
| 1993
|
The use of monozygotic and dizygotic twins to estimate the effects of inheritance on the levels of immunoglobulin isotypes and antibodies to phosphocholine.
Clinical immunology and immunopathology.
66:176-180.
1993
|
|
| 1992
|
Evidence for a Clonal Origin of Relative Penicillin Resistance among Type 9L Pneumococci in Northwestern Canada.
Journal of Infectious Diseases.
165:671-675.
1992
|
|
| 1992
|
A 'safe-site' for Salmonella typhimurium is within splenic polymorphonuclear cells.
Microbial Pathogenesis.
13:181-190.
1992
|
|
| 1992
|
Analysis of pneumococcal PspA microheterogeneity in SDS polyacrylamide gels and the association of PspA with the cell membrane.
Microbial Pathogenesis.
13:343-355.
1992
|
|
| 1992
|
Geographic Distribution of Penicillin-Resistant Clones of Streptococcus pneumoniae: Characterization by Penicillin-Binding Protein Profile, Surface Protein A Typing, and Multilocus Enzyme Analysis.
Clinical Infectious Diseases.
15:112-118.
1992
|
|
| 1992
|
In Vivo Administration of Bryostatin 1, a Protein Kinase C Activator, Decreases Murine Resistance to Salmonella typhimurium.
Cancer Research.
52:2143-2147.
1992
|
|
| 1992
|
Molecular localization of variable and conserved regions of pspA and identification of additional pspA homologous sequences in Streptococcus pneumoniae.
Microbial Pathogenesis.
13:261-269.
1992
|
|
| 1992
|
Mouse antibody to phosphocholine can protect mice from infection with mouse-virulent human isolates of Streptococcus pneumoniae.
Infection and Immunity.
60:1957-1962.
1992
|
|
| 1992
|
Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae.
Infection and Immunity.
60:111-116.
1992
|
|
| 1992
|
Structural properties and evolutionary relationships of PspA, a surface protein of Streptococcus pneumoniae, as revealed by sequence analysis.
Journal of Bacteriology.
174:601-609.
1992
|
|
| 1992
|
Truncated forms of PspA that are secreted from Streptococcus pneumoniae and their use in functional studies and cloning of the pspA gene.
Journal of Bacteriology.
174:610-618.
1992
|
|
| 1991
|
The salmonella typhlmurium locus mv/a regulates virulence in itys but not ityr mice: Functional mv/a results in avirulence; mutant (nonfunctional) mv/a results in virulence.
Journal of Experimental Medicine.
174:1073-1083.
1991
|
|
| 1991
|
A 'safe-site' for Salmonella typhimurium is within splenic cells during the early phase of infection in mice.
Microbial Pathogenesis.
10:297-310.
1991
|
|
| 1991
|
A 43-kilodalton pneumococcal surface protein, PspA: Isolation, protective abilities, and structural analysis of the amino-terminal sequence.
Infection and Immunity.
59:1285-1289.
1991
|
|
| 1991
|
A hemA mutation renders Salmonella typhimurium avirulent in mice, yet capable of eliciting protection against intravenous infection with S. typhimurium.
Microbial Pathogenesis.
11:289-295.
1991
|
|
| 1991
|
Antigen-Independent Selection of T15 Idiotype During B-Cell Ontogeny in Mice.
Autoimmunity.
1:203-212.
1991
|
|
| 1991
|
Epidemiologic studies of group 9 pneumococci in terms of protein type and 9N versus 9V capsular type.
Journal of Infectious Diseases.
163:812-818.
1991
|
|
| 1991
|
Mouse hepatitis virus strain UAB infection enhances resistance to Salmonella typhimurium in mice by inducing suppression of bacterial growth.
Infection and Immunity.
59:852-856.
1991
|
|
| 1991
|
PspA, a surface protein of Streptococcus pneumonia, is capable of eliciting protection against pneumococci of more than one capsular type.
Infection and Immunity.
59:222-228.
1991
|
|
| 1990
|
Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae.
Infection and Immunity.
58:3293-3299.
1990
|
|
| 1990
|
The primary effect of the Ity locus is on the rate of growth of Salmonella typhimurium that are relatively protected from killing.
Journal of Immunology.
144:3143-3151.
1990
|
|
| 1990
|
Variation in the molecular weight of PspA (pneumococcal surface protein A) among Streptococcus pneumoniae.
Microbial Pathogenesis.
8:61-69.
1990
|
|
| 1989
|
Age-related change in anti-carbohydrate antibody levels.
American Journal of Epidemiology.
129:89-96.
1989
|
|
| 1989
|
Antipneumococcal effects of C-reactive protein and monoclonal antibodies to pneumococcal cell wall and capsular antigens.
Infection and Immunity.
57:1457-1464.
1989
|
|
| 1989
|
IgG anti-DNA autoantibodies within an individual autoimmune mouse are the products of clonal selection.
Journal of Immunology.
142:4269-4274.
1989
|
|
| 1989
|
Modulation of resistance to Salmonella typhimurium infection in mice by mouse hepatitis virus (MHV).
Microbial Pathogenesis.
6:81-91.
1989
|
|
| 1989
|
Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae.
Infection and Immunity.
57:2037-2042.
1989
|
|
| 1988
|
A pneumococcal surface protein (PspB) that exhibits the same protease sensitivity as streptococcal R antigen.
Infection and Immunity.
56:3001-3003.
1988
|
|
| 1988
|
Cross-reactive monoclonal antibodies for diagnosis of pneumococcal meningitis.
Journal of Clinical Microbiology.
26:1635-1640.
1988
|
|
| 1988
|
Host resistance to mucosal gram-negative infection. Susceptibility of lipopolysaccharide nonresponder mice.
Journal of Immunology.
140:3180-3185.
1988
|
|
| 1988
|
Human IgG subclasses and their relation to carbohydrate antigen immunocompetence.
Diagnostic immunology.
5:241-248.
1988
|
|
| 1988
|
Protein serotyping of Streptococcus pneumoniae based on reactivity to six monoclonal antibodies.
Microbial Pathogenesis.
5:159-167.
1988
|
|
| 1988
|
Role of pneumococcal surface protein A in the virulence of Streptococcus pneumoniae..
Reviews of infectious diseases.
10 Suppl 2.
1988
|
|
| 1987
|
Circulating parasite antigen(s) in lymphatic filariasis: Use of monoclonal antibodies to phosphocholine for immunodiagnosis.
Journal of Immunology.
138:3454-3460.
1987
|
|
| 1987
|
Human antibodies to phosphocholine. IgG anti-PC antibodies express restricted numbers of V and C regions.
Journal of Immunology.
138:3325-3331.
1987
|
|
| 1987
|
Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein a (PspA).
Journal of Experimental Medicine.
165:381-394.
1987
|
|
| 1987
|
A protective monoclonal antibody that reacts with a novel antigen of pneumococcal teichoic acid.
Microbial Pathogenesis.
3:249-260.
1987
|
|
| 1987
|
Blood clearance of Streptococcus pneumoniae by C-reactive protein.
Journal of Immunology.
138:2598-2603.
1987
|
|
| 1987
|
Naturally occurring antibodies to phosphocholine as a potential index of antibody responsiveness to polysaccharides.
Journal of Infectious Diseases.
155:1307-1314.
1987
|
|
| 1986
|
Patients with Wiskott-Aldrich Syndrome have normal IgG2 levels.
Journal of Immunology.
137:3484-3487.
1986
|
|
| 1986
|
Analysis of a surface protein of Streptococcus pneumoniae recognised by protective monoclonal antibodies.
Microbial Pathogenesis.
1:519-531.
1986
|
|
| 1986
|
Effects of in vitro growth phase on the pathogenesis of Salmonella typhimurium in mice.
Journal of general microbiology.
132:1283-1295.
1986
|
|
| 1986
|
Genetic approaches to the study of disease resistance: with special emphasis on the use of recombinant inbred mice..
Current Topics in Microbiology and Immunology.
124:21-35.
1986
|
|
| 1986
|
Genetic control of the susceptibility to pneumococcal infection..
Current Topics in Microbiology and Immunology.
124:103-120.
1986
|
|
| 1986
|
Genetic mapping of novel virulence determinants of Salmonella typhimurium to the region between trpD and supD.
Microbial Pathogenesis.
1:115-124.
1986
|
|
| 1986
|
Independence of macrophage activation and expression of the alleles of the Ity (immunity to typhimurium) locus.
Microbial Pathogenesis.
1:33-41.
1986
|
|
| 1986
|
Natural and vaccine-related immunity to streptococcus pneumoniae.
Journal of Infectious Diseases.
154:245-256.
1986
|
|
| 1986
|
Salmonella typhimurium virulence genes necessary to exploit the Ity(s/s) genotype of the mouse.
Infection and Immunity.
51:872-878.
1986
|
|
| 1986
|
Transformation of encapsulated Streptococcus pneumoniae.
Journal of Bacteriology.
168:1463-1465.
1986
|
|
| 1985
|
Induction of germ-line anti-α1-3 dextran antibody responses in mice by members of the enterobacteriaceae family.
Journal of Immunology.
135:3468-3472.
1985
|
|
| 1985
|
The ability of Salmonella typhimurium to produce the siderophore enterobactin is not a virulence factor in mouse typhoid.
Infection and Immunity.
50:392-397.
1985
|
|
| 1985
|
Genetic factors in host resistance to urinary tract infection.
Infection.
13.
1985
|
|
| 1985
|
Genetic factors in host resistance to urinary tract infection.
Infection.
13.
1985
|
|
| 1985
|
Antiidiotypic antibodies.
Methods in Enzymology.
VOL. 116:174-189.
1985
|
|
| 1985
|
Blood clearance of pneumococci by C-reactive protein.
Federation proceedings.
44.
1985
|
|
| 1985
|
Evidence for separate genetic defects in C3H/HeJ and C3HeB/FeJ mice, that affect susceptibility to gram-negative infections.
Journal of Immunology.
134:4118-4122.
1985
|
|
| 1985
|
Monoclonal antibodies against idiotopes on human anti-hapten antibodies.
Federation proceedings.
44.
1985
|
|
| 1984
|
Blood clearance by anti-phosphocholine antibodies as a mechanism of protection in experimental pneumococcal bacteremia.
Journal of Immunology.
133:3308-3312.
1984
|
|
| 1984
|
The effects of subclass on the ability of anti-phosphocholine antibodies to protect mice from fatal infection with Streptococcus pneumoniae.
The Journal of molecular and cellular immunology : JMCI.
1:305-309.
1984
|
|
| 1984
|
Monoclonal antibodies to Salmonella lipopolysaccharide: Anti-O-polysaccharide antibodies protect C3H mice against challenge with virulent Salmonella typhimurium.
Journal of Immunology.
133:950-957.
1984
|
|
| 1984
|
Monoclonal antibodies against protease-sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus Pneumoniae.
Journal of Experimental Medicine.
160:386-397.
1984
|
|
| 1984
|
Lack of IgA subclass restriction in antibody response to phosphorylcholine, β lactoglobulin and tetanus toxoid.
Immunology.
53:419-426.
1984
|
|
| 1984
|
Monoclonal antibodies against surface polypeptides on mouse virulent strains of Streptococcus pneumoniae.
Federation proceedings.
43.
1984
|
|
| 1984
|
The J606-GAC subset of antibody is composed of the products of several - different variable region gene segments.
Federation proceedings.
43.
1984
|
|
| 1984
|
The effects of idiotype on the ability of IgG1 antiphosphorylcholine antibodies to protect mice from fatal infection with Streptococcus pneumoniae.
European Journal of Immunology.
14:1027-1030.
1984
|
|
| 1984
|
The mouse heavy chain variable region marker, J606-GAC, is not restricted to particular B cell isotypes or subsets.
Journal of Immunology.
132:783-786.
1984
|
|
| 1983
|
DEFICIENT IgA SYNTHESIS VIEWED IN THE CONTEXT OF NORMAL DEVELOPMENT OF IgA B‐CELLS.
Annals of the New York Academy of Sciences.
409:461-468.
1983
|
|
| 1983
|
Epidemiological studies of Streptococcus pneumoniae in infants: Development of antibody to phosphocholine.
Journal of Clinical Microbiology.
18:1102-1107.
1983
|
|
| 1983
|
Resistance to Streptococcus pneumoniae is induced by a phosphocholine-protein conjugate.
Journal of Immunology.
130:2871-2875.
1983
|
|
| 1983
|
Ten percent of normal B cells and plasma cells share A V(H) determinants) (J606-GAC) with a distinct subset of murine V(H)III plasmacytomas.
Journal of Immunology.
130:2423-2428.
1983
|
|
| 1982
|
Erratum: Mouse IgG3 antibodies are highly protective against infection with Streptococcuspneumoniae (Nature (1981) 294, (88-90)).
Nature.
295:438.
1982
|
|
| 1982
|
Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus Pneumoniae.
Journal of Experimental Medicine.
156:1177-1185.
1982
|
|
| 1982
|
Streptococcal group A carbohydrate has properties of both a thymus-independent (TI-2) and a thymus-dependent antigen.
Journal of Immunology.
128:2032-2035.
1982
|
|
| 1982
|
Anti-DNA autoantibodies in (NZB x NZW)F1 mice are clonally heterogeneous, but the majority share a common idiotype.
Journal of Immunology.
128:668-674.
1982
|
|
| 1982
|
Estimate of the light chain repertoire size of fetal and adult BALB/cJ and CBA/J mice.
Journal of Immunology.
129:673-677.
1982
|
|
| 1982
|
Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in mice.
Journal of Immunology.
128:2374-2376.
1982
|
|
| 1982
|
Protection of mice from infection with Streptococcus pneumoniae by anti-phosphocholine antibody.
Infection and Immunity.
36:184-188.
1982
|
|
| 1981
|
Mouse IgG3 antibodies are highly protective against infection with Streptococcus pneumoniae.
Nature.
294:88-90.
1981
|
|
| 1981
|
Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 Streptococcus pneumoniae.
Journal of Experimental Medicine.
153:694-705.
1981
|
|
| 1981
|
A genetic locus responsible for salmonella susceptibility in BSVS mice is not responsible for the limited T-dependent immune responsiveness of BSVS mice.
Journal of Immunology.
127:906-911.
1981
|
|
| 1981
|
A simple method for estimating the probable numbers of different antibodies by examining the repeat frequencies of sequences or isoelectric focusing patterns.
Molecular Immunology.
18:29-38.
1981
|
|
| 1981
|
Phagocytosis and killing of Salmonella typhimurium by peritoneal exudate cells.
Infection and Immunity.
33:380-388.
1981
|
|
| 1980
|
Clonal nature of the immune response. II. The effect of immunization of clonal commitment.
Journal of Experimental Medicine.
152:151-160.
1980
|
|
| 1980
|
Isoelectric focusing of immunoglobulins: Improved methodology.
Journal of Immunological Methods.
33:101-115.
1980
|
|
| 1979
|
Immune response deficiency of BSVS mice. II. Generalized deficiency to thymus‐dependent antigens.
European Journal of Immunology.
9:255-261.
1979
|
|
| 1978
|
Light chain diversity of murine anti-streptococcal antibodies: IgC(H)-linked effects on L chain expression.
Journal of Immunology.
121:149-158.
1978
|
|
| 1978
|
Subclass restriction of murine anti-carbohydrate antibodies.
Journal of Immunology.
121:566-572.
1978
|
|
| 1978
|
Analysis of the diversity of murine antibodies to dextran B1355. III. Idiotypic and spectrotypic correlations.
European Journal of Immunology.
8:352-359.
1978
|
|
| 1977
|
Analysis of the diversity of murine antibodies to dextran B1355. II. Demonstration of multiple idiotypes with variable expression in several strains.
Journal of Immunology.
119:1406-1412.
1977
|
|
| 1977
|
Complete sharing of light chain spectrotypes by murine IgM and IgG anti streptococcal antibodies.
Journal of Immunology.
118:2161-2166.
1977
|
|
| 1977
|
Immune response deficiency of BSVS mice - I. Identification of Ir gene differences between A/J and BSVS mice in the antistreptococcal group A carbohydrate response.
Immunogenetics.
4:381-392.
1977
|
|
| 1976
|
Analysis of the diversity of murine antibodies to dextran B1355. I. Generation of a large, pauci clonal response by a bacterial vaccine.
Journal of Immunology.
117:569-575.
1976
|
|
| 1975
|
Clonal dominance. I. Restricted nature of the IgM antibody response to group A streptococcal carbohydrate in mice.
Journal of Experimental Medicine.
141:1291-1307.
1975
|
|
| 1975
|
Detection of isoelectric focused antibody by autoradiography and hemolysis of antigen-coated erythrocytes. A comparison of methods.
Journal of Immunological Methods.
8:363-372.
1975
|
|
| 1974
|
Mouse strain specific idiotypy and interstrain idiotypic cross reactions.
Journal of Immunology.
113:522-530.
1974
|
|
| 1974
|
Idiotypic uniformity of cell surface immunoglobulin in chronic lymphocytic leukemia: Evidence for monoclonal proliferation.
Journal of Experimental Medicine.
140:1416-1420.
1974
|
|
| 1974
|
Restriction of early IgM antibody response to streptococcal group A carbohydrate.
Federation proceedings.
33:3390.
1974
|
|
| 1972
|
Mouse antibodies to group A streptococcal carbohydrate; use of idiotypy to detect inbred strain specificity and to monitor spleen cell transfer in syngenetic mice..
Journal of Immunology.
109:1311-1320.
1972
|
|
